In our analysis, compared with patients with 1p19q codeletion and IDH mutation alone,MLLT11 expression is higher in the combination of the two, indicating that the expression pattern ofMLLT11 has a similar role in predicting the prognosis of glioma patients as that of 1p19q deletion and IDH mutation. The gene discussed is MLLT11; the disease is central nervous system cancer.